Credit Minxmrphd

Excerpt:

"In the meanwhile, Sacha is already trying to make leronlimab easier to use. He received a five-year, $3-million NIH grant in August 2020 to develop a concentrated, longer-lasting formulation of leronlimab that could allow it to be injected every three months. Less-frequent injections can increase drug regimen adherence, and therefore improve drug effectiveness."

Informed knowledge of LL, the Mab, is spreading and important news in the scientific community. Outside/Public/Private Researchers and Grants$ re: LL are just the beginning.


https://www.investorvillage.com/smbd.asp?mb=1...d=22694118